Sales PlanSales Plan • May 31st, 2006 • Estate of Howard S. Stern • Surgical & medical instruments & apparatus • New York
Sales Plan, dated as of the date set forth on the signature page (the “Sales Plan”), between Linda Stern (“Seller”) and Goldman, Sachs & Co. (“Broker”).
ContractJoint Filing Agreement • January 23rd, 2006 • Estate of Howard S. Stern • Surgical & medical instruments & apparatus
EXHIBIT 10.7 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D dated January 23, 2006, with respect to the common stock, par value of $0.01 of AngioDynamics, Inc., a Delaware corporation, is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934. IN WITNESS WHEREOF, the undersigned have each executed this Joint Filing Agreement as of January 23, 2006.
LOCK UP AGREEMENTLock Up Agreement • May 31st, 2006 • Estate of Howard S. Stern • Surgical & medical instruments & apparatus
The undersigned is an owner of record or beneficially, or a pledgee of, certain shares of common stock of the Company (“Common Stock”) or securities convertible into or exchangeable or exercisable for Common Stock. The Company proposes to carry out a public offering of Common Stock (the “Offering”) for which you will act as representatives (the “Representatives”) of the several underwriters (the “Underwriters”). The undersigned recognizes that the Offering will be of benefit to the undersigned and will benefit the Company by, among other things, raising additional capital for its operations. The undersigned acknowledges that you will be relying upon the representations and agreements of the undersigned contained in this letter in carrying out the Offering and in entering into underwriting arrangements with the Company with respect to the Offering (the “Underwriting Agreement”).
ContractJoint Filing Agreement • January 23rd, 2006 • Estate of Howard S. Stern • In vitro & in vivo diagnostic substances
EXHIBIT 10.5 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D dated January 23, 2006, with respect to the common stock, par value of $0.10 of E-Z-EM, Inc., a Delaware corporation, is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934. IN WITNESS WHEREOF, the undersigned have each executed this Joint Filing Agreement as of January 23, 2006.
